The global biologics market is growing due to the awareness of their benefits together with an increasing prevalence of chronic diseases such as cancer, diabetes and arthritis.
This new industry trend report provides a comprehensive review of the markets for biologics and gene therapy. The size of the global biologics market, including new biologic entities, cell and gene therapies, and biosimilars, is expected to reach $319 billion by 2021. In this trend report, learn more about the current trends in gene therapies and next-gen biologics, as well as:
- Challenges specific to these types of drugs
- Expert insight from top SMEs in the field
- Future projections